As a defect in early-phase insulin secretion is a hallmark of glucose intolerance [117], enhancement of early-phase insulin secretion but not prolonged hyperinsulinemia by glinides is more physiological, unlike SUs, and is assumed to increase beta cell workload as well as risk of hypoglycemia to a lesser degree compared with SUs. The gene discussed is INS; the disease is Hypoglycemia.